Immunology

  1. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes

    1. Tongqing Zhou
    2. I-Ting Teng
    3. Adam S. Olia
    4. Gabriele Cerutti
    5. Jason Gorman
    6. Alexandra Nazzari
    7. Wei Shi
    8. Yaroslav Tsybovsky
    9. Lingshu Wang
    10. Shuishu Wang
    11. Baoshan Zhang
    12. Yi Zhang
    13. Phinikoula S. Katsamba
    14. Yuliya Petrova
    15. Bailey B. Banach
    16. Ahmed S. Fahad
    17. Lihong Liu
    18. Sheila N. Lopez Acevedo
    19. Bharat Madan
    20. Matheus Oliveira de Souza
    21. Xiaoli Pan
    22. Pengfei Wang
    23. Jacy R. Wolfe
    24. Michael Yin
    25. David D. Ho
    26. Emily Phung
    27. Anthony DiPiazza
    28. Lauren A. Chang
    29. Olubukola M. Abiona
    30. Kizzmekia S. Corbett
    31. Brandon J. DeKosky
    32. Barney S. Graham
    33. John R. Mascola
    34. John Misasi
    35. Tracy Ruckwardt
    36. Nancy J. Sullivan
    37. Lawrence Shapiro
    38. Peter D. Kwong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells

    1. Blerina Ahmetaj-Shala
    2. Ricky Vaja
    3. Santosh S Atanur
    4. Peter M. George
    5. Nicholas S. Kirkby
    6. Jane A. Mitchell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Distinct antibody repertoires against endemic human coronaviruses in children and adults

    1. Taushif Khan
    2. Mahbuba Rahman
    3. Fatima Al Ali
    4. Susie S.Y. Huang
    5. Manar Ata
    6. Qian Zhang
    7. Paul Bastard
    8. Zhiyong Liu
    9. Emmanuelle Jouanguy
    10. Vivien Beziat
    11. Aurélie Cobat
    12. Gheyath K. Nasrallah
    13. Hadi M. Yassine
    14. Maria K. Smatti
    15. Amira Saeed
    16. Isabelle Vandernoot
    17. Jean-Christophe Goffard
    18. Guillaume Smits
    19. Isabelle Migeotte
    20. Filomeen Haerynck
    21. Isabelle Meyts
    22. Laurent Abel
    23. Jean-Laurent Casanova
    24. Mohammad R. Hasan
    25. Nico Marr

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations

    1. Christof Jungbauer
    2. Lukas Weseslindtner
    3. Lisa Weidner
    4. Simon Gänsdorfer
    5. Maria R. Farcet
    6. Eva Gschaider‐Reichhart
    7. Thomas R. Kreil

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

    1. Reid Rubsamen
    2. Scott Burkholz
    3. Christopher Massey
    4. Trevor Brasel
    5. Tom Hodge
    6. Lu Wang
    7. Charles Herst
    8. Richard Carback
    9. Paul Harris

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

    1. Susanne N. Walker
    2. Neethu Chokkalingam
    3. Emma L. Reuschel
    4. Mansi Purwar
    5. Ziyang Xu
    6. Ebony N. Gary
    7. Kevin Y. Kim
    8. Michaela Helble
    9. Katherine Schultheis
    10. Jewell Walters
    11. Stephanie Ramos
    12. Kar Muthumani
    13. Trevor R. F. Smith
    14. Kate E. Broderick
    15. Pablo Tebas
    16. Ami Patel
    17. David B. Weiner
    18. Daniel W. Kulp

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Analysis of SARS-CoV-2 specific T-cell receptors in ImmuneCode reveals cross-reactivity to immunodominant Influenza M1 epitope

    1. John-William Sidhom
    2. Alexander S. Baras

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Cross-Neutralization Activity Against SARS-CoV-2 is Present in Currently Available Intravenous Immunoglobulins

    1. José María Díez
    2. Carolina Romero
    3. Júlia Vergara-Alert
    4. Melissa Belló-Perez
    5. Jordi Rodon
    6. José Manuel Honrubia
    7. Joaquim Segalés
    8. Isabel Sola
    9. Luis Enjuanes
    10. Rodrigo Gajardo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19

    1. Anna E. Oja
    2. Anno Saris
    3. Cherien A. Ghandour
    4. Natasja A.M. Kragten
    5. Boris M. Hogema
    6. Esther J. Nossent
    7. Leo M.A. Heunks
    8. Susan Cuvalay
    9. Ed Slot
    10. Francis H. Swaneveld
    11. Hans Vrielink
    12. Theo Rispens
    13. Ellen van der Schoot
    14. René A.W. van Lier
    15. Anja Ten Brinke
    16. Pleun Hombrink

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses

    1. Arinjay Banerjee
    2. Nader El-Sayes
    3. Patrick Budylowski
    4. Daniel Richard
    5. Hassaan Maan
    6. Jennifer A. Aguiar
    7. Kaushal Baid
    8. Michael R. D’Agostino
    9. Jann Catherine Ang
    10. Benjamin J.-M. Tremblay
    11. Sam Afkhami
    12. Mehran Karimzadeh
    13. Aaron T. Irving
    14. Lily Yip
    15. Mario Ostrowski
    16. Jeremy A. Hirota
    17. Robert Kozak
    18. Terence D. Capellini
    19. Matthew S. Miller
    20. Bo Wang
    21. Samira Mubareka
    22. Allison J. McGeer
    23. Andrew G. McArthur
    24. Andrew C. Doxey
    25. Karen Mossman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 34 of 173 Next